Sharepoint Solutions
PRODUCTS
-
The AMERICAN Earthquake Joint System (Patent 10,436,367) combines the rugged, tough, and time-proven deflection performance of AMERICAN’s Flex-Ring restrained joint pipe with the capacity to expand and contract.
-
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.
-
“Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.
-
CAI’s Kneat: Data Ready provides you with best-in-class content and templates created by industry-leaders, giving you a headstart in implementing your own Kneat solution.
Kneat: Data Ready offers not only templates, but a validated out-of-the-box configuration that you can tailor to your business needs. Implement your Kneat instance in less than half the time.
-
Expediting the customer journey from discovery all the way through commercial release.
WHITE PAPERS AND CASE STUDIES
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing
An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
-
AqueoUS Vets Named A Manufacturing Partner For A Southern CA Water Treatment Facility
In August 2018, Aqueous Vets was selected over existing industry incumbents to supply the Granular Activated Carbon Systems (GACS) for a Southern California Water Treatment Plant.
-
Advancing Dose Escalation Strategies With Bayesian Modeling
A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Modern Lentiviral Platforms For Scalable Cell Therapy
A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Patient-Defined Recruitment: The Movement Advanced By COVID-19
The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.
-
GMP Calibration Management
Learn why generic EAM systems fall short in regulated industries and how purpose-built solutions ensure compliance, efficiency, and audit readiness.
-
Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies
Meeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
NEWS
-
EPA Approves New WIFIA Loans To Strengthen Drinking Water And Wastewater Infrastructure In Oregon And Washington12/18/2025
Today, U.S. Environmental Protection Agency (EPA) is announcing its approval of three Water Infrastructure Finance and Innovation Act (WIFIA) loans totaling $240M.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
Merck To Acquire US Biopharma Company SpringWorks Therapeutics To Accelerate Sustainable Growth Of Healthcare Business4/28/2025
Merck, a leading science and technology company, and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks.
-
Rapeseed Protein For Vegan Burger Patties And Nutritious Chicken Feed8/13/2025
Food products containing proteins from plants, fungi or algae are becoming increasingly popular. Researchers at the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, Germany, have now shown that previously rarely used rapeseed proteins are also a valuable source of protein alternatives: using the EthaNa process, they extract not only high-quality rapeseed oil from rapeseed but also a protein-rich rapeseed kernel concentrate, which can be processed for instance into burger patties and pasta or used as a nutritious feed in poultry fattening.
-
Ohio Sea Grant Releases 2025 Summary Of ODHE Harmful Algal Bloom Research Initiative12/18/2025
Ohio Sea Grant, on behalf of The Ohio State University, The University of Toledo and the Ohio Department of Higher Education (ODHE), has released the 2025 research findings update for the statewide Harmful Algal Bloom Research Initiative (HABRI).